These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 8816486)

  • 21. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene.
    Muller WJ; Sinn E; Pattengale PK; Wallace R; Leder P
    Cell; 1988 Jul; 54(1):105-15. PubMed ID: 2898299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors.
    Siegel PM; Dankort DL; Hardy WR; Muller WJ
    Mol Cell Biol; 1994 Nov; 14(11):7068-77. PubMed ID: 7935422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.
    Rudolph-Owen LA; Chan R; Muller WJ; Matrisian LM
    Cancer Res; 1998 Dec; 58(23):5500-6. PubMed ID: 9850086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of hyperplasias, preneoplasias, and mammary tumors in MMTV-c-erbB-2 and MMTV-TGFalpha transgenic rats.
    Davies BR; Platt-Higgins AM; Schmidt G; Rudland PS
    Am J Pathol; 1999 Jul; 155(1):303-14. PubMed ID: 10393862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression.
    Hutchinson J; Jin J; Cardiff RD; Woodgett JR; Muller WJ
    Mol Cell Biol; 2001 Mar; 21(6):2203-12. PubMed ID: 11238953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
    Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
    J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
    Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P
    Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolactin potentiates transforming growth factor alpha induction of mammary neoplasia in transgenic mice.
    Arendt LM; Rose-Hellekant TA; Sandgren EP; Schuler LA
    Am J Pathol; 2006 Apr; 168(4):1365-74. PubMed ID: 16565509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein-tyrosine phosphatase epsilon. An isoform specifically expressed in mouse mammary tumors initiated by v-Ha-ras OR neu.
    Elson A; Leder P
    J Biol Chem; 1995 Nov; 270(44):26116-22. PubMed ID: 7592814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Over-expression of erbB-2/neu is paralleled by inhibition of mouse-mammary-epithelial-cell differentiation and developmental apoptosis.
    Lazar H; Baltzer A; Gimmi C; Marti A; Jaggi R
    Int J Cancer; 2000 Feb; 85(4):578-83. PubMed ID: 10699933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
    Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor beta1.
    Muraoka RS; Koh Y; Roebuck LR; Sanders ME; Brantley-Sieders D; Gorska AE; Moses HL; Arteaga CL
    Mol Cell Biol; 2003 Dec; 23(23):8691-703. PubMed ID: 14612410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells.
    Smith GH; Sharp R; Kordon EC; Jhappan C; Merlino G
    Am J Pathol; 1995 Oct; 147(4):1081-96. PubMed ID: 7573353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse.
    Campbell MJ; Wollish WS; Lobo M; Esserman LJ
    In Vitro Cell Dev Biol Anim; 2002 Jun; 38(6):326-33. PubMed ID: 12513120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signaling through ShcA is required for transforming growth factor beta- and Neu/ErbB-2-induced breast cancer cell motility and invasion.
    Northey JJ; Chmielecki J; Ngan E; Russo C; Annis MG; Muller WJ; Siegel PM
    Mol Cell Biol; 2008 May; 28(10):3162-76. PubMed ID: 18332126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of aromatase overexpression on mammary growth and gene expression in the aromatase x transforming growth factor alpha double transgenic mice.
    Kirma N; Mandava U; Wuichet K; Tekmal RR
    J Steroid Biochem Mol Biol; 2001 Nov; 78(5):419-26. PubMed ID: 11738552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice.
    Matsui Y; Halter SA; Holt JT; Hogan BL; Coffey RJ
    Cell; 1990 Jun; 61(6):1147-55. PubMed ID: 2161707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation.
    Gorska AE; Jensen RA; Shyr Y; Aakre ME; Bhowmick NA; Moses HL
    Am J Pathol; 2003 Oct; 163(4):1539-49. PubMed ID: 14507660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice.
    Niemeyer CC; Spencer-Dene B; Wu JX; Adamson ED
    Int J Cancer; 1999 May; 81(4):588-91. PubMed ID: 10225449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors.
    Liu JC; Deng T; Lehal RS; Kim J; Zacksenhaus E
    Cancer Res; 2007 Sep; 67(18):8671-81. PubMed ID: 17875707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.